HOXB9 and gastric carcinoma: HOXB9 was found to be overexpressed in lung adenocarcinoma and human breast cancer, whereas in colon adenocarcinoma, pancreatic ductal adenocarcinoma and gastric carcinoma patients, its expression is decreased15–19,21.